Mr Michael Aldridge, CEO of Hexima, presented today at AusBiotech’s “Australia Biotech Invest & Partnering Conference 2021”.
AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy. The “Australia Biotech Invest & Partnering Conference 2021” represents the preeminent opportunity for companies to present their technology and story to a network of potential international partners and investors.
View a recording of the presentation and Q&A session here → AusBiotech Recording
